— Whittal A, Epstein J, Lazareva Y, Cole A, Jommi C, Barros PP, Wollaert L, Patris J.
Value & Outcomes Spotlight. 2025.
Related articles
Expanding patient access to multi-indication medicines through innovative agreements
Multi-indication Medicines28/10/2025
Supporting patients with underserved autoimmune diseases: Challenges and opportunities for innovative medicines
Multi-indication Medicines14/09/2025
Pricing and reimbursement of multiple indication medicines: Can a balance be found between different stakeholder perspectives to optimise value and access for patients, while ensuring sustainable and affordable innovation?
Multi-indication Medicines17/11/2024